You have landed on a page of the archived Cochrane Community website. This site is not being maintained or updated.

If you are looking for Cochrane Review evidence, please visit Cochrane’s evidence page.

If you are a Cochrane contributor looking for Community resources, please visit the new Cochrane Community website.

Cervical cancer

Warning: Parameter 2 to onepixelout_swftools_flashvars() expected to be a reference, value given in module_invoke() (line 476 of /var/www/archive/includes/

To browse Podcasts by topic, please visit the new Cochrane Summaries site here

Developed in collaboration with the Evidence-Based Migrant Health Guidelines Team

Dr. Kevin Pottie will describe the key points of the Cervical cancer review of the Canadian Collaboration for Immigrant and Refugee Health Evidence-based clinical guidelines

Key points

  • Vaccination against HPV is recommended for 9- to 26-year-old female patients to reduce invasive changes related to cervical cancer.
  • All sexually active women should be screened for cervical abnormalities (with Papanicolaou smear) to detect and treat invasive changes.
  • Providing clear information about cervical screening, building rapport and offering access to a female practitioner improves acceptance of Pap tests.
  • Immigrant girls might miss out on school vaccination programs depending on their age upon arrival in Canada.

CMAJ Evidence review

Evidence Based Migrant Health Network

Play Now!

You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.

Download [mp3]  | Read Review
Updated on: May 7, 2012, 11:43

Comments for improvement or correction are welcome.